Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • General
  • Health Care
  • Initiation
  • Large Cap
  • News
  • Trading Ideas

Investors Underestimate Power Of This Pieced Flywheel: Analyst Kicks Off Coverage On CVS Health

By Vandana Singh
April 21, 3:52 PM
As a part of a broader coverage of 15 companies in the Healthcare Services sector, Cantor Fitzgerald initiated coverage on CVS…

CVS

Read More
2 minute read
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Short Ideas
  • Trading Ideas

Top 5 Health Care Stocks That May Collapse

By Lisa Levin
March 31, 9:10 AM
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

ACHV

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

TD Cowen Downgrades Oak Street Health to Market Perform, Raises Price Target to $39

By Benzinga Newsdesk
March 15, 9:51 AM
TD Cowen analyst Gary Taylor downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform and raises the price target from $34 to $39.

OSH

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News
  • Price Target

Bernstein Downgrades Oak Street Health to Market Perform, Raises Price Target to $39

By Benzinga Newsdesk
February 15, 6:41 AM
Bernstein analyst Lance Wilkes downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform and raises the price target from $35 to $39.

OSH

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Raymond James Downgrades Oak Street Health to Market Perform

By Benzinga Newsdesk
February 10, 6:02 AM
Raymond James analyst John Ransom downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform.

OSH

Read More
1 minute read
  • Analyst Ratings
  • Downgrades
  • News

Jefferies Downgrades Oak Street Health to Hold

By Benzinga Newsdesk
February 9, 6:38 AM
Jefferies analyst Brian Tanquilut downgrades Oak Street Health (NYSE:OSH) from Buy to Hold.

OSH

Read More
2 minute read
  • Analyst Ratings

Expert Ratings for Oak Street Health

By Benzinga Insights
February 8, 5:01 PM
Over the past 3 months, 7 analysts have published their opinion on Oak Street Health (NYSE:OSH) stock. These…

OSH

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

SVB Leerink Maintains Market Perform on Oak Street Health, Raises Price Target to $39

By Benzinga Newsdesk
February 8, 9:27 AM
SVB Leerink analyst Whit Mayo maintains Oak Street Health (NYSE:OSH) with a Market Perform and raises the price target from $33 to $39.

OSH

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights
February 7, 1:31 PM
Gainers Lixte Biotech Hldgs (NASDAQ:LIXT) shares rose 97.3% to $1.6 during Tuesday’s regular session. Trading volume for this…

CDIO

Read More
1 minute read
  • Management
  • News

Oak Street Health States That Its Policy Is Not To Comment On Unusual Market Activity

By Happy Mohamed
February 7, 11:20 AM
Oak Street Health, Inc.

CVS

Posts pagination

1 2 … 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service